X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    FDA Accepts BLA for Recommended

    FDA Accepts BLA for Recommended Biosimilar to Simponi

    Merck to Acquire Verona

    Merck to Acquire Verona Pharma in $10B Deal Boosts COPD Drug

    Emerging Oral Small Molecule Drugs

    Emerging Oral Small-Molecule Drugs for Ultra-Rare Diseases

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    FDA Accepts BLA for Recommended

    FDA Accepts BLA for Recommended Biosimilar to Simponi

    Merck to Acquire Verona

    Merck to Acquire Verona Pharma in $10B Deal Boosts COPD Drug

    Emerging Oral Small Molecule Drugs

    Emerging Oral Small-Molecule Drugs for Ultra-Rare Diseases

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home News

New Zealand approves use of Pfizer-BioNtechs Covid-19 vaccine

Content Team by Content Team
14th February 2021
in News
Allergy Alarm Raised On Pfizer-BioNTech COVID-19 Vaccine

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

The New Zealand Government has granted formal approval for use of Pfizer and BioNTech’s Covid-19 vaccine as a critical step to ensure the vaccine is safe and effective.

Last week, the New Zealand Medicines and Medical Devices Safety Authority, Medsafe, granted provisional approval for the vaccine.

Covid-19 Response Minister Chris Hipkins said: “The government is continuing to go by the book and has carefully considered the ‘decision to use’ the Pfizer / BioNTech vaccine as part of our nationwide programme.

“As part of our portfolio, we have secured up to 750,000 courses of the Pfizer Covid-19 vaccine through an Advance Purchase Agreement, and we are seeking a further small allocation through the COVAX Facility.

“We will start vaccinating our border workers within days of arrival and then the people they live with.”

Last October, Pfizer and BioNTech entered an agreement with the New Zealand government to supply 1.5 million doses of their Covid-19 vaccine.

Initially, the country also plans to inoculate cleaners, nurses who undertake health checks in MIQ, security staff, customs and border officials, airline staff and hotel workers.

Medsafe is currently in regular talks with AstraZeneca and Janssen and has also initiated engagement with Novavax.

In a separate development, a subject expert committee of India’s Central Drugs Standard Control Organisation (CDSCO) granted approval to Bharat Biotech to begin Phase I clinical trial of an intranasal Covid-19 vaccine candidate.

The latest move comes after the committee approved the revised protocol.

Meanwhile, scientists at the University of Maryland School of Medicine (UMSOM) in the US found promising results in pre-clinical studies of Novavax’s new experimental Covid-19 vaccine candidate, NVX-CoV2373.

NVX-CoV2373 is a stabilised, prefusion protein antigen derived from genetic sequence of SARS-CoV-2 spike (S) protein and has Novavax’s proprietary adjuvant Matrix M.

The vaccine generated a robust immune response in animals exposed to the vaccine with robust data signifying its safety and efficacy.

The results initiated human trials of the vaccine in the US with a Phase III trial launched at the UMSOM’s Center for Vaccine Development and Global Health.
https://www.pharmaceutical-technology.com/news/new-zealand-approves-pfizer-vaccine/

Previous Post

Algernon Pharmaceuticals Considers Adding Lung Scarring as an Additional Endpoint for its Phase 2b/3 COVID-19 Study Protocol

Next Post

Samsung Biologics, National OncoVenture, and Eutilex obtains IND Approval from FDA

Related Posts

FDA Accepts BLA for Recommended
FDA Approvals

FDA Accepts BLA for Recommended Biosimilar to Simponi

22nd July 2025
Merck to Acquire Verona
Drug Development

Merck to Acquire Verona Pharma in $10B Deal Boosts COPD Drug

21st July 2025
ChiRhoClin LogiCare3PL Partners for Drug Distribution
News

ChiRhoClin, LogiCare3PL Partners for Drug Distribution

21st July 2025
Thermo Fisher and Sanofi Partners
Manufacturing

Thermo Fisher and Sanofi Partners for US Drug Manufacturing

21st July 2025
EMA Recommendations to Secure Anti D Immunoglobulins Supply
News

EMA Recommendations to Secure Anti-D Immunoglobulins Supply

15th July 2025
FDA Approves Oral Therapy for Treating Hereditary Angioedema
FDA Approvals

FDA Approves Oral Therapy for Treating Hereditary Angioedema

15th July 2025
Next Post
Samsung BioLogics

Samsung Biologics, National OncoVenture, and Eutilex obtains IND Approval from FDA

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In